Monday 8 April 2019 - 7.15 - 8.15am (includes breakfast) - Registration required
'Is there a role for opioids in patients with chronic non-cancer pain?
Presenter: Professor Milton Cohen
The role of opioids in the management of patients with chronic non-cancer pain is the subject of hotly contested controversy that essentially pitches evidence against empiricism. This session is not intended to resolve this controversy but rather to provide a map and compass to help the clinician navigate these difficult waters more effectively. Discussion will revolve around the following themes:
Tuesday 9 April 2019, 7.15 – 8.15 am (includes breakfast)
Sublingual Ketamine Wafer: Phase 2b Results of Wafermine in Acute Post-Operative Pain
Presenters: Janakan Krishnarajah and Stephan Schug
Dr Krishnarajah, Chief Medical Officer of iX Biopharma Ltd, will present clinical trial results from the recently completed US Phase 2b study of Wafermine (sublingual ketamine wafer) in acute, moderate to severe post-operative pain.
Prof Stephan Schug, Chair of Anaesthesiology and Pain Medicine (UWA) and Director of Pain Medicine (Royal Perth Hospital), will provide an update on the latest research on the use of Ketamine for pain management.